Form 4: Candel Therapeutics CEO Paul Peter Tak Sells Shares to Cover Tax Obligations
SEC Form 4
Candel Therapeutics CEO Paul Peter Tak sold 20,293 shares of common stock on July 11, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On July 11, 2024, Paul Peter Tak, the CEO of Candel Therapeutics, Inc., sold 20,293 shares of common stock.
- The sale was executed at a price of $5.9734 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting and settlement of restricted stock units, as per the company's mandatory sell-to-cover policy.
- Following the transaction, Tak directly owns 353,263 shares of Candel Therapeutics.
Sentiment
Score: 5
Explanation: The Form 4 filing itself is a neutral event. The sale is related to tax obligations, which is a routine financial activity. Therefore, the sentiment is neutral.
Industry Context
Sales to cover tax obligations are a common practice among executives receiving equity compensation. This transaction reflects the standard procedure for managing tax liabilities associated with stock vesting.
Key Dates
| Date | Description |
|---|---|
| 07/11/2024 | Date of stock sale transaction |
| 07/15/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.